Impact of Topiramate on Daily Activities in Migraine Patients
Author Information
Author(s): Carl Dahlöf, Elizabeth Loder, Merle Diamond, Marcia Rupnow, George Papadopoulos, Lian Mao
Primary Institution: Gothenburg Migraine Clinic
Hypothesis
Does topiramate improve daily activities and patient functioning in migraine patients?
Conclusion
Topiramate significantly improved daily activities and patient functioning for those achieving a 50% reduction in migraine frequency.
Supporting Evidence
- Topiramate 100 mg/d significantly improved Migraine-Specific Questionnaire scores versus placebo.
- Patients on topiramate had significantly less migraine-related disruption of daily activities.
- 46% of topiramate-treated patients were ≥ 50% responders compared to 23% on placebo.
Takeaway
Taking topiramate helps people with migraines feel better and do more things every day.
Methodology
Pooled analyses of data from three randomized, double-blind, placebo-controlled trials assessing the effects of topiramate on migraine frequency and daily activities.
Potential Biases
Potential bias due to the nature of the trials and the reporting of self-reported outcomes.
Limitations
The study may not fully assess the impact of adverse events of drug treatment.
Participant Demographics
Mean age 39.8 years, 86% female, predominantly Caucasian.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website